Injectable medications originally developed for the treatment of diabetes are also effective for weight loss, and have surged ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

(NASDAQ:MTVA) announced positive results from the Phase 1 Part 2 multiple ascending dose (MAD) trial of DA-1726 in obesity.

So far this year, Pfizer shares have dropped 17.4%, while Novo Nordisk's stock has tumbled 24% and Lilly shares have slipped 3.2%. The SPDR S&P Pharmaceuticals ETF XPH has shed 12.1% year to date and ...

Real-time index price for TSX Oil and Gas EW Index (TXOE), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Former speed skater Sarah Lindsay, 44, believes injections like Ozempic and Mounjaro are causing users to be malnourished and ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

Yerba mate has so many people saying it’s helped them lose weight that it’s kind of hard to ignore—some are even comparing it to the weight loss injectable, Wegovy. But is drinking it a ...

Right now, Lilly trades at a forward price to earnings (P/E) multiple of 36. As the chart below illustrates, Lilly's current forward P/E is roughly 40% lower today than it was just a year ago.

Forbes contributors publish independent expert analyses and insights. I’m an ER doc, public health researcher and patient advocate.